[HTML][HTML] Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use
S Jinno, B Anker, P Kaur, CC Bristow… - BMC infectious …, 2013 - Springer
Background The optimal treatment of early syphilis (primary, secondary and early latent) in
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
[HTML][HTML] Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use
S Jinno, B Anker, P Kaur… - BMC Infectious …, 2013 - bmcinfectdis.biomedcentral.com
The optimal treatment of early syphilis (primary, secondary and early latent) in HIV-infected
patients remains controversial. The Center for Diseases Control STD Treatment Guidelines …
patients remains controversial. The Center for Diseases Control STD Treatment Guidelines …
[PDF][PDF] Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use
S Jinno, B Anker, P Kaur, CC Bristow, JD Klausner - 2013 - scienceopen.com
Background: The optimal treatment of early syphilis (primary, secondary and early latent) in
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
[PDF][PDF] Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use
S Jinno, B Anker, P Kaur, CC Bristow, JD Klausner - 2013 - aidshealth.org
Background: The optimal treatment of early syphilis (primary, secondary and early latent) in
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use.
S Jinno, B Anker, P Kaur, CC Bristow… - BMC Infectious …, 2013 - search.ebscohost.com
Background The optimal treatment of early syphilis (primary, secondary and early latent) in
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use.
S Jinno, B Anker, P Kaur, CC Bristow… - BMC Infectious …, 2013 - europepmc.org
Background The optimal treatment of early syphilis (primary, secondary and early latent) in
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use.
S Jinno, B Anker, P Kaur, CC Bristow, JD Klausner - 2013 - cabidigitallibrary.org
Background: The optimal treatment of early syphilis (primary, secondary and early latent) in
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use
S Jinno, B Anker, P Kaur, CC Bristow… - BMC Infectious …, 2013 - go.gale.com
Background Despite a significant decrease in syphilis cases in the United States during the
1990s, syphilis incidence has risen dramatically since 2000 [1]. Its prevalence remains …
1990s, syphilis incidence has risen dramatically since 2000 [1]. Its prevalence remains …
Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use
S Jinno, B Anker, P Kaur, CC Bristow… - BMC Infectious …, 2013 - search.proquest.com
The optimal treatment of early syphilis (primary, secondary and early latent) in HIV-infected
patients remains controversial. The Center for Diseases Control STD Treatment Guidelines …
patients remains controversial. The Center for Diseases Control STD Treatment Guidelines …
[HTML][HTML] Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use
S Jinno, B Anker, P Kaur, CC Bristow… - BMC Infectious …, 2013 - ncbi.nlm.nih.gov
Background The optimal treatment of early syphilis (primary, secondary and early latent) in
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …
HIV-infected patients remains controversial. The Center for Diseases Control STD Treatment …